n SA Pharmaceutical Journal - Accessing essential medicines in the South African public healthcare sector via section 21 - NDoH news

Volume 86 Number 6
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017


Like all national medicines regulatory bodies, the South African Health Products Regulatory Authority (SAHPRA), previously the Medicines Control Council of South Africa, is responsible for ensuring that all South Africans access medicines that are safe, efficacious and of good quality.1 A basic tenet of medicines regulatory practice is to require that all medicines on the domestic market are registered and therefore that their marketing and sale is authorised. There are, however, circumstances where access to an unregistered medicine is needed, requiring an exceptional mechanism to be employed. In South Africa that exceptional mechanism, which allows for the sale of unregistered medicines, is provided by section 21 of the Medicines and Related Substances Act, 1965 (the Medicines Act). This article describes the circumstances under which the South African public health sector would need to have recourse to section 21, and the required processes that would enable such access.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error